RE: aslypius9 Nov 2013 12:49
Absolutely, fair enough. I think I have a longer investment timeframe per individual investment than you - nothing wrong with that. On the other hand, with Albemarle at the present time, there are relatively short-term events coming up which will shed much light on the value of the presently issued equity, so that investors may be proven "right" or "wrong" much faster than with a typical investment.
For what it's worth I'd be very happy if, after the effect of some exceptional write-downs and restructuring costs, the company's net tangible book value has not dramatically deteriorated over the past year. I would probably participate in a rights issue but, from the perspective of an external observer, it seems to me that the company should not need as much as the £35 million which was demanded from EZCORP. That £35 million (if it is really needed to get rid of the bank threat), added to a market cap for the presently issued shares of about £20 million, suggests a price of £55 million for what would then be an extremely well-capitalised company with a huge backing in tangible assets, and earnings which ought to normalise after restructuring at least around £5 million p/a (something close to what H&T, which I also own, can earn in the current environment).
There is risk in any special situation such as this. I invested in H&T before this A&B situation emerged: H&T's management struck me as having a very strong financial pedigree, whereas A&B's management were predominantly from a retail background. Pawnbroking is a financial business, so I wanted financial people. H&T had a bigger pledge book and a more sensible expansion plan. But there is still plenty of value in A&B, in my very humble opinion.
Best of luck Galvy.
Long: ABM & HAT. Dyor, etc